Immunotherapy

A four-step rush-induction protocol ending with 0.05 mL of the 1:10 v/v concentration was safe for patients at the beginning of aeroallergen therapy, according to a letter published in Annals of Allergy, Asthma & Immunology.

MADRID — Tarlatamab exhibited antitumor activity among patients with small cell lung cancer who received prior treatment, according to results of the DeLLphi-301 study presented at ESMO Congress.

Fred Hutchinson Cancer Center appointed Lawrence Fong, MD, as scientific director of the Immunotherapy Integrated Research Center.

A young girl growing up in revolutionary-era Iran had a clear but lofty goal — cure cancer.

White patients and those with nonoropharyngeal cancer and advanced disease appeared more likely to receive immunotherapy for head and neck cancer squamous cell carcinoma, according to study results.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about treatment options for advanced recurrent endometrial cancer.

Results from the American Association for Cancer Research’s annual Cancer Progress Report revealed that the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2020.

Patients experienced smaller skin test wheal responses due to reduced levels of content in recently recalled peanut allergen extract, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Immune checkpoint inhibitors may confer benefit to certain patients with advanced penile squamous cell carcinoma, according to retrospective study results.

ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic agent intended as a “functional cure” for patients with chronic hepatitis B virus infection.